Asymmetric Targeted DBS for PD With PIGD — ATS-PIGD  

Parkinson Disease Clinical Trial

Official title: Deep Brain Stimulation of Asymmetric Targets Versus Bilateral Subthalamic Nucleus (STN) for Parkinson's Disease With Postural Instability/Gait Difficulty: a Prospective, Randomized, Double-blinded Trial

Status Recruiting

Clinical Trial Summary

The purpose of this study is to compare the effectiveness of the deep brain stimulation of asymmetric targets [subthalamic nucleus (STN) in the right hemisphere while globus pallidus interna (GPi) in the left] versus the bilateral STN for the treatment of Parkinson's disease (PD) with postural instability/gait difficulty (PIGD) in a randomized, double-blinded manner.

Clinical Trial Description

This is a double-blinded, randomized, controlled trial aiming at comparing the efficacy of asymmetric targets and bilateral STN DBS in treating PD with PIGD.

After being informed about the study and potential risks, enrolled patients giving written informed consent will be screened to determine eligibility for study entry. Patients who meet the eligibility requirements will be randomized into two groups in a 1:1 ratio using a minimization randomization method in a double-blinded manner, and later undergo bilateral DBS surgery. One group of patients will receive stimulation of left GPi and right STN, while the other will receive STN stimulation bilaterally. The follow-up period will be one year, with corresponding clinical assessments completed at six months and one year postoperatively. ;

Related Conditions & MeSH terms

• Parkinson Disease

• NCT number: NCT05397340
• Study type: Interventional
• Source: Ruijin Hospital
• Contact: Dianyou Li, MD, PhD
• Phone: +0086-021-64370045
• Email: ldy11483@rjh.com.cn
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2022
• Completion date: December 31, 2024